Reperfusion and calculated RISKs: pharmacological postconditioning of human myocardium

Area of Science:

• Cardiology
• Pharmacology
• Cellular Biology

Background:

• Myocardial reperfusion injury remains a significant challenge in acute myocardial infarction, potentially limiting the benefits of timely reperfusion.
• Experimental and clinical studies highlight the detrimental effects of reperfusion-associated injury on salvaging ischemic myocardium.

Discussion:

• Mudalagiri et al. investigated the protective effects of erythropoietin on simulated reperfusion injury in human isolated myocardium.
• The study observed that erythropoietin administration specifically during re-oxygenation conferred protection against injury.
• This finding is crucial as it demonstrates a therapeutic window for intervention during the reperfusion phase.

Key Insights:

• Erythropoietin demonstrated a protective effect against simulated reperfusion injury in human myocardium.
• The protective benefits were contingent upon the activation of PI3-kinase/Akt and ERK1/2 pathways.
• These pathways are identified as reperfusion injury salvage kinases (RISKs), crucial for myocardial survival.

Outlook:

• This study provides a critical proof-of-principle that activating RISKs is protective in human myocardium.
• Erythropoietin represents a potential pharmacological strategy, though other approaches may also emerge.
• Targeting RISK pathways offers a promising therapeutic avenue for managing acute myocardial infarction.